Trademark: 74364309
Status Date
Friday, April 3, 2020
Registration Number
1937436
Registration Date
Tuesday, November 21, 1995
Filing Date
Wednesday, March 3, 1993
Published for Opposition
Tuesday, August 31, 1993
Cancellation Date
Friday, April 3, 2020
5 pharmaceutical preparations for prevention and/or treatment of antibody-mediated diseases; namely, systemic lupus erythematosus; [ Rh hemolytic disease of the newborn; antiphospholipid antibody syndrome; Grave's disease; myasthenia gravis; Hashimoto's thyroiditis; pemphigus; autoimmune hemolytic anemia; autoimmune thrombocytopenia purpura; antibody mediated infertility; Sjogre's syndrome; mixed connective tissue disease; glomerulonephritis and Goodpasture's syndrome ]
Apr 3, 2020
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Jun 18, 2007
Case File In Ticrs
Mar 3, 2006
Registered And Renewed (First Renewal - 10 Yrs)
Mar 3, 2006
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Mar 1, 2006
Assigned To Paralegal
Sep 27, 2005
Registered - Combined Section 8 (10-Yr) & Sec. 9 Filed
Sep 27, 2005
Teas Section 8 & 9 Received
Jan 10, 2002
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Oct 15, 2001
Registered - Sec. 8 (6-Yr) & Sec. 15 Filed
Nov 21, 1995
Registered-Principal Register
Aug 21, 1995
Allowed Principal Register - Sou Accepted
Jul 10, 1995
Correspondence Received In Law Office
Jan 10, 1995
Non-Final Action Mailed
Dec 1, 1994
Statement Of Use Processing Complete
Oct 20, 1994
Use Amendment Filed
Sep 8, 1994
Extension 1 Granted
May 6, 1994
Extension 1 Filed
Nov 23, 1993
Noa Mailed - Sou Required From Applicant
Aug 31, 1993
Published For Opposition
Aug 2, 1993
Notice Of Publication
Jun 1, 1993
Approved For Pub - Principal Register
May 21, 1993
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
